Posted On: 10/16/2015 10:15:59 AM
Post# of 29744
IMNP DD Notes
$IMNP ~ Immune Pharmaceuticals Inc. due diligence report
$IMNP recent news/filings
## source: finance.yahoo.com
Thu, 15 Oct 2015 15:00:00 GMT ~ IMNP: Large Market Opportunity for Bertilimumab in the Treatment of Inflammatory Bowel Diseases
read full: http://finance.yahoo.com/news/imnp-large-mark...00484.html
*********************************************************
Thu, 15 Oct 2015 14:32:20 GMT ~ Immune Pharmaceuticals to Present at Dawson James Growth Stock Conference
[at noodls] - NEW YORK, Oct. 15, 2015/PRNewswire / -- Immune Pharmaceuticals Inc. (NASDAQ: IMNP) today announced, that Dr. Daniel Teper, CEO will present at the Dawson James Securities Growth Stock Conference today, ...
read full: http://www.noodls.com/view/CD0A454A40984AC1D3...445D96AE81
*********************************************************
Thu, 15 Oct 2015 13:39:00 GMT ~ Immune Pharmaceuticals to Present at Dawson James Growth Stock Conference
[PR Newswire] - This conference provides a platform to meet institutional funds, family offices and high net worth accredited investors and will be held at the Wyndham Grand Hotel in Jupiter, Florida. Immune's lead product candidate, bertilimumab, is in clinical development for moderate-to-severe ulcerative colitis as well as for bullous pemphigoid, an orphan auto-immune dermatological condition. Other indications considered for development include atopic dermatitis, Crohn's disease, severe asthma and NASH (inflammatory liver disease).
read full: http://finance.yahoo.com/news/immune-pharmace...00464.html
*********************************************************
Wed, 14 Oct 2015 15:11:20 GMT ~ CEO of Immune Pharmaceuticals Buys 19,000 Shares of Company
read full: http://finance.yahoo.com/news/ceo-immune-phar...20824.html
*********************************************************
Wed, 07 Oct 2015 12:24:13 GMT ~ Immune Pharmaceuticals Submits Investigational New Drug Application (IND) in the U.S. for its Lead Product Candidate Bertilimumab for the Treatment of Bullous Pemphigoid
[at noodls] - NEW YORK, Oct. 7, 2015/PRNewswire / -- Immune Pharmaceuticals, Inc. (NASDAQ: IMNP) ('Immune' or the 'Company') announced today that it has submitted an Investigational New Drug Application in the U.S. ...
read full: http://www.noodls.com/view/414F4229AC2EEEBBBF...D48F2AA233
*********************************************************
$IMNP charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$IMNP company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/IMNP/company-info
Ticker: $IMNP
OTC Market Place: Not Available
CIK code: 0001208261
Company name: Immune Pharmaceuticals Inc.
Company website: http://www.immunepharmaceuticals.com
Incorporated In: DE, USA
Business Description: Immune Pharmaceuticals Inc. is focused on developing the next generation of monoclonal antibodies to address significant unmet medical needs in the treatment of cancer and inflammatory diseases. Our goal is to improve patients' lives through targeted medicine.
$IMNP share structure
## source: otcmarkets.com
Market Value: $36,275,310 a/o Oct 15, 2015
Shares Outstanding: 27,071,127 a/o Aug 13, 2015
Float: Not Available
Authorized Shares: 225,000,000 a/o Jan 14, 2010
Par Value: Not Available
$IMNP extra dd links
Company name: Immune Pharmaceuticals Inc.
Company website: http://www.immunepharmaceuticals.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=IMNP+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=IMNP+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=IMNP+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/IMNP/news - http://finance.yahoo.com/q/h?s=IMNP+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/IMNP/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/IMNP/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=IMNP+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/IMNP
DTCC (dtcc.com): http://search2.dtcc.com/?q=Immune+Pharmaceuti...ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&am...ticals+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results...=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.immun...ticals.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.immu...icals.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.immun...ticals.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/compa...yword/IMNP
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/financials?...-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/IMNP/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/IMNP/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?...rch=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=IMNP
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/IMNP/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=IMNP+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=IMNP+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=IMNP
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=IMNP
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=IMNP+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/IMNP/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=IMNP+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/IMNP.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=IMNP
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/IMNP/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/IMNP
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/IMNP
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/IMNP:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=IMNP
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/st...icker=IMNP
contact us at ddnotesmaker [at] gmail [dot] com for requests/feed
$IMNP DD Notes ~ http://www.ddnotesmaker.com/IMNP
$IMNP ~ Immune Pharmaceuticals Inc. due diligence report
$IMNP recent news/filings
## source: finance.yahoo.com
Thu, 15 Oct 2015 15:00:00 GMT ~ IMNP: Large Market Opportunity for Bertilimumab in the Treatment of Inflammatory Bowel Diseases
read full: http://finance.yahoo.com/news/imnp-large-mark...00484.html
*********************************************************
Thu, 15 Oct 2015 14:32:20 GMT ~ Immune Pharmaceuticals to Present at Dawson James Growth Stock Conference
[at noodls] - NEW YORK, Oct. 15, 2015/PRNewswire / -- Immune Pharmaceuticals Inc. (NASDAQ: IMNP) today announced, that Dr. Daniel Teper, CEO will present at the Dawson James Securities Growth Stock Conference today, ...
read full: http://www.noodls.com/view/CD0A454A40984AC1D3...445D96AE81
*********************************************************
Thu, 15 Oct 2015 13:39:00 GMT ~ Immune Pharmaceuticals to Present at Dawson James Growth Stock Conference
[PR Newswire] - This conference provides a platform to meet institutional funds, family offices and high net worth accredited investors and will be held at the Wyndham Grand Hotel in Jupiter, Florida. Immune's lead product candidate, bertilimumab, is in clinical development for moderate-to-severe ulcerative colitis as well as for bullous pemphigoid, an orphan auto-immune dermatological condition. Other indications considered for development include atopic dermatitis, Crohn's disease, severe asthma and NASH (inflammatory liver disease).
read full: http://finance.yahoo.com/news/immune-pharmace...00464.html
*********************************************************
Wed, 14 Oct 2015 15:11:20 GMT ~ CEO of Immune Pharmaceuticals Buys 19,000 Shares of Company
read full: http://finance.yahoo.com/news/ceo-immune-phar...20824.html
*********************************************************
Wed, 07 Oct 2015 12:24:13 GMT ~ Immune Pharmaceuticals Submits Investigational New Drug Application (IND) in the U.S. for its Lead Product Candidate Bertilimumab for the Treatment of Bullous Pemphigoid
[at noodls] - NEW YORK, Oct. 7, 2015/PRNewswire / -- Immune Pharmaceuticals, Inc. (NASDAQ: IMNP) ('Immune' or the 'Company') announced today that it has submitted an Investigational New Drug Application in the U.S. ...
read full: http://www.noodls.com/view/414F4229AC2EEEBBBF...D48F2AA233
*********************************************************
$IMNP charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$IMNP company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/IMNP/company-info
Ticker: $IMNP
OTC Market Place: Not Available
CIK code: 0001208261
Company name: Immune Pharmaceuticals Inc.
Company website: http://www.immunepharmaceuticals.com
Incorporated In: DE, USA
Business Description: Immune Pharmaceuticals Inc. is focused on developing the next generation of monoclonal antibodies to address significant unmet medical needs in the treatment of cancer and inflammatory diseases. Our goal is to improve patients' lives through targeted medicine.
$IMNP share structure
## source: otcmarkets.com
Market Value: $36,275,310 a/o Oct 15, 2015
Shares Outstanding: 27,071,127 a/o Aug 13, 2015
Float: Not Available
Authorized Shares: 225,000,000 a/o Jan 14, 2010
Par Value: Not Available
$IMNP extra dd links
Company name: Immune Pharmaceuticals Inc.
Company website: http://www.immunepharmaceuticals.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=IMNP+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=IMNP+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=IMNP+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/IMNP/news - http://finance.yahoo.com/q/h?s=IMNP+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/IMNP/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/IMNP/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=IMNP+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/IMNP
DTCC (dtcc.com): http://search2.dtcc.com/?q=Immune+Pharmaceuti...ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&am...ticals+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results...=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.immun...ticals.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.immu...icals.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.immun...ticals.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/compa...yword/IMNP
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/financials?...-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/IMNP/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/IMNP/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?...rch=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=IMNP
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/IMNP/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=IMNP+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=IMNP+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=IMNP
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=IMNP
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=IMNP+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/IMNP/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=IMNP+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/IMNP.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=IMNP
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/IMNP/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/IMNP/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/IMNP
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/IMNP
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/IMNP:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=IMNP
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/st...icker=IMNP
contact us at ddnotesmaker [at] gmail [dot] com for requests/feed
$IMNP DD Notes ~ http://www.ddnotesmaker.com/IMNP
(0)
(0)
